Face new challenges

Leapfrog your competition with new business models

As Life Science companies look to leapfrog their competition by accelerating innovation, maximizing ROI, and creating new, connected patient experiences, we will see a significant growth in collaborative invention, and new models will emerge throughout manufacturing and value chain.

As the focus shifts from products to patients, Life Sciences companies must move beyond traditional "one-size-fits-all" approaches to supply chains. The leaders will seek to understand the desired outcomes for the patients and for the business and then design the end-to-end integrated value chain accordingly to those objectives - adopting new business models with distributed supply chains, extending and maximizing the value chain ecosystem by contracting out services that were previously performed in house, focusing on patient empowerment and complementing solutions with experiences.

Adopt the strategy

Propell your organization to the next level

The 3DEXPERIENCE® platform provides companies with quick and efficient access to up-to-date and trustworthy data from multiple, heterogeneous sources. Thanks to Dassault Systèmes’ analytics technology that uses business logic analysis of complex product structures and data models, pertinent design information is revealed, measured, analyzed and displayed in user-customized dashboards.

The 3DEXPERIENCE® platform goes beyond therapy development and manufacturing, by enabling sales and marketing teams to create stunning visuals of the device design to illustrate its function to clinicians during sales engagements. Coupled with augmented and virtual reality technology, the same visuals can be brought to life in 3D to help close the knowledge gap between patient and clinician vernacular enabling the patient to better understand their condition and the procedure to correct it.

Success story

3D Printing in Life Sciences - The Future is Already Here